Concepts (309)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Vitamin D | 25 | 2018 | 171 | 3.690 |
Why?
|
| Vitamin D Deficiency | 17 | 2018 | 89 | 2.790 |
Why?
|
| Obesity | 27 | 2019 | 1063 | 2.290 |
Why?
|
| Aging | 24 | 2019 | 881 | 2.170 |
Why?
|
| Body Composition | 17 | 2019 | 365 | 1.890 |
Why?
|
| Weight Loss | 12 | 2019 | 413 | 1.710 |
Why?
|
| Mobility Limitation | 7 | 2017 | 187 | 1.580 |
Why?
|
| Aged | 71 | 2019 | 9487 | 1.410 |
Why?
|
| Overweight | 6 | 2018 | 256 | 1.310 |
Why?
|
| Body Mass Index | 24 | 2019 | 865 | 1.270 |
Why?
|
| Exercise | 7 | 2019 | 591 | 1.220 |
Why?
|
| European Continental Ancestry Group | 26 | 2018 | 1131 | 1.210 |
Why?
|
| Physical Fitness | 5 | 2012 | 119 | 1.210 |
Why?
|
| Life Style | 7 | 2018 | 364 | 1.160 |
Why?
|
| Polymorphism, Single Nucleotide | 21 | 2018 | 1079 | 1.150 |
Why?
|
| Caloric Restriction | 4 | 2019 | 92 | 1.110 |
Why?
|
| Female | 77 | 2019 | 18164 | 1.100 |
Why?
|
| Male | 74 | 2019 | 17807 | 1.080 |
Why?
|
| Dietary Proteins | 6 | 2019 | 50 | 0.970 |
Why?
|
| Humans | 87 | 2019 | 29093 | 0.900 |
Why?
|
| Prospective Studies | 24 | 2019 | 2019 | 0.870 |
Why?
|
| Eating | 3 | 2017 | 73 | 0.820 |
Why?
|
| Diabetes Mellitus, Type 2 | 6 | 2018 | 1379 | 0.820 |
Why?
|
| Independent Living | 4 | 2019 | 78 | 0.800 |
Why?
|
| Accidental Falls | 3 | 2015 | 204 | 0.780 |
Why?
|
| Muscle Strength | 6 | 2017 | 139 | 0.750 |
Why?
|
| Motor Activity | 6 | 2015 | 310 | 0.750 |
Why?
|
| Genome-Wide Association Study | 15 | 2018 | 543 | 0.740 |
Why?
|
| Parathyroid Hormone | 5 | 2012 | 38 | 0.730 |
Why?
|
| Dietary Supplements | 6 | 2018 | 170 | 0.700 |
Why?
|
| African Continental Ancestry Group | 10 | 2018 | 350 | 0.680 |
Why?
|
| Disabled Persons | 2 | 2012 | 83 | 0.670 |
Why?
|
| Pennsylvania | 8 | 2018 | 77 | 0.620 |
Why?
|
| Tennessee | 8 | 2018 | 97 | 0.620 |
Why?
|
| Amino Acids | 1 | 2017 | 41 | 0.590 |
Why?
|
| Vitamins | 3 | 2015 | 58 | 0.570 |
Why?
|
| Middle Aged | 29 | 2019 | 10829 | 0.560 |
Why?
|
| Muscle, Skeletal | 7 | 2019 | 494 | 0.550 |
Why?
|
| Homebound Persons | 1 | 2015 | 8 | 0.540 |
Why?
|
| Follow-Up Studies | 13 | 2019 | 2108 | 0.540 |
Why?
|
| Cholecalciferol | 1 | 2015 | 21 | 0.540 |
Why?
|
| Food Services | 1 | 2015 | 18 | 0.540 |
Why?
|
| Cohort Studies | 19 | 2018 | 1687 | 0.510 |
Why?
|
| Body Weight | 5 | 2017 | 290 | 0.500 |
Why?
|
| Behavior Therapy | 1 | 2014 | 89 | 0.490 |
Why?
|
| Health Status | 8 | 2018 | 368 | 0.470 |
Why?
|
| Blood Glucose | 7 | 2019 | 466 | 0.460 |
Why?
|
| Activities of Daily Living | 5 | 2014 | 238 | 0.450 |
Why?
|
| Diet | 6 | 2019 | 354 | 0.440 |
Why?
|
| Feeding Behavior | 4 | 2017 | 159 | 0.440 |
Why?
|
| African Americans | 9 | 2018 | 1373 | 0.440 |
Why?
|
| Genetic Loci | 6 | 2018 | 147 | 0.430 |
Why?
|
| Cross-Sectional Studies | 12 | 2018 | 1356 | 0.430 |
Why?
|
| Dairy Products | 2 | 2017 | 12 | 0.420 |
Why?
|
| Proportional Hazards Models | 7 | 2014 | 709 | 0.420 |
Why?
|
| Incidence | 11 | 2019 | 1119 | 0.420 |
Why?
|
| Depression | 1 | 2014 | 380 | 0.410 |
Why?
|
| Geriatric Assessment | 9 | 2019 | 355 | 0.410 |
Why?
|
| Nutritional Status | 4 | 2014 | 68 | 0.400 |
Why?
|
| Risk Factors | 17 | 2019 | 3531 | 0.400 |
Why?
|
| Aged, 80 and over | 13 | 2019 | 3717 | 0.400 |
Why?
|
| Hand Strength | 4 | 2018 | 85 | 0.390 |
Why?
|
| Insulin | 4 | 2015 | 346 | 0.390 |
Why?
|
| Nutrition Policy | 2 | 2011 | 33 | 0.380 |
Why?
|
| Randomized Controlled Trials as Topic | 5 | 2019 | 464 | 0.380 |
Why?
|
| Energy Intake | 7 | 2019 | 120 | 0.370 |
Why?
|
| Diet, Reducing | 4 | 2019 | 90 | 0.360 |
Why?
|
| Mortality | 4 | 2015 | 109 | 0.360 |
Why?
|
| Diet Surveys | 5 | 2019 | 56 | 0.350 |
Why?
|
| Retirement | 1 | 2008 | 11 | 0.340 |
Why?
|
| United States | 15 | 2018 | 3630 | 0.330 |
Why?
|
| Linear Models | 7 | 2018 | 426 | 0.320 |
Why?
|
| Heart Diseases | 2 | 2018 | 97 | 0.310 |
Why?
|
| Cognition | 4 | 2016 | 526 | 0.310 |
Why?
|
| Muscular Atrophy | 1 | 2008 | 67 | 0.310 |
Why?
|
| Diabetes Mellitus | 2 | 2008 | 366 | 0.310 |
Why?
|
| Longitudinal Studies | 7 | 2018 | 720 | 0.300 |
Why?
|
| Nutrition Assessment | 4 | 2011 | 54 | 0.290 |
Why?
|
| Genotype | 8 | 2018 | 735 | 0.290 |
Why?
|
| Gait | 3 | 2013 | 115 | 0.290 |
Why?
|
| Vegetables | 2 | 2010 | 35 | 0.280 |
Why?
|
| Adult | 16 | 2018 | 8420 | 0.280 |
Why?
|
| Fruit | 2 | 2010 | 53 | 0.280 |
Why?
|
| Pilot Projects | 2 | 2019 | 469 | 0.270 |
Why?
|
| Ethnic Groups | 3 | 2017 | 440 | 0.270 |
Why?
|
| Lung | 2 | 2018 | 233 | 0.250 |
Why?
|
| Thinness | 2 | 2015 | 31 | 0.230 |
Why?
|
| Diet, Mediterranean | 2 | 2014 | 23 | 0.230 |
Why?
|
| Confidence Intervals | 3 | 2009 | 140 | 0.230 |
Why?
|
| Alleles | 5 | 2014 | 251 | 0.220 |
Why?
|
| Proteins | 2 | 2014 | 140 | 0.220 |
Why?
|
| Meat | 2 | 2015 | 15 | 0.220 |
Why?
|
| Sex Factors | 6 | 2018 | 631 | 0.220 |
Why?
|
| Cognition Disorders | 3 | 2014 | 390 | 0.210 |
Why?
|
| Adipose Tissue | 3 | 2011 | 327 | 0.210 |
Why?
|
| Frail Elderly | 2 | 2019 | 65 | 0.200 |
Why?
|
| Thigh | 2 | 2019 | 39 | 0.200 |
Why?
|
| Respiratory Function Tests | 2 | 2018 | 111 | 0.190 |
Why?
|
| Genetic Predisposition to Disease | 8 | 2018 | 836 | 0.190 |
Why?
|
| Risk Assessment | 5 | 2018 | 1305 | 0.180 |
Why?
|
| Chronic Disease | 2 | 2012 | 369 | 0.180 |
Why?
|
| Chi-Square Distribution | 4 | 2012 | 293 | 0.180 |
Why?
|
| Sarcopenia | 2 | 2017 | 53 | 0.170 |
Why?
|
| Dietary Fats | 3 | 2014 | 108 | 0.170 |
Why?
|
| Age Factors | 5 | 2018 | 1108 | 0.170 |
Why?
|
| Vitamin K | 1 | 2018 | 9 | 0.170 |
Why?
|
| Random Allocation | 1 | 2019 | 213 | 0.160 |
Why?
|
| Disability Evaluation | 3 | 2019 | 211 | 0.160 |
Why?
|
| Bone and Bones | 1 | 2019 | 87 | 0.160 |
Why?
|
| Lung Diseases | 1 | 2018 | 45 | 0.160 |
Why?
|
| Vesicular Transport Proteins | 1 | 2018 | 10 | 0.160 |
Why?
|
| Seafood | 1 | 2017 | 11 | 0.160 |
Why?
|
| Eicosapentaenoic Acid | 1 | 2017 | 26 | 0.160 |
Why?
|
| Docosahexaenoic Acids | 1 | 2017 | 20 | 0.160 |
Why?
|
| Inflammation | 2 | 2012 | 507 | 0.160 |
Why?
|
| Appetite | 1 | 2017 | 19 | 0.150 |
Why?
|
| Osteoarthritis, Knee | 1 | 2018 | 80 | 0.150 |
Why?
|
| Bone Density | 1 | 2019 | 182 | 0.150 |
Why?
|
| Heart | 1 | 2018 | 161 | 0.150 |
Why?
|
| Genome, Human | 2 | 2018 | 129 | 0.150 |
Why?
|
| Absorptiometry, Photon | 4 | 2014 | 129 | 0.150 |
Why?
|
| Walking | 3 | 2013 | 177 | 0.150 |
Why?
|
| Lower Extremity | 1 | 2018 | 93 | 0.150 |
Why?
|
| Urinary Incontinence | 1 | 2017 | 45 | 0.150 |
Why?
|
| Genetics, Population | 1 | 2017 | 30 | 0.150 |
Why?
|
| Dietary Carbohydrates | 2 | 2014 | 21 | 0.150 |
Why?
|
| Mendelian Randomization Analysis | 2 | 2014 | 12 | 0.150 |
Why?
|
| Prevalence | 4 | 2018 | 896 | 0.150 |
Why?
|
| Membrane Proteins | 2 | 2018 | 256 | 0.140 |
Why?
|
| Odds Ratio | 4 | 2017 | 447 | 0.140 |
Why?
|
| Stroke Volume | 1 | 2018 | 278 | 0.140 |
Why?
|
| Time Factors | 5 | 2015 | 2001 | 0.140 |
Why?
|
| Meat Products | 1 | 2015 | 3 | 0.140 |
Why?
|
| Health Behavior | 3 | 2014 | 214 | 0.140 |
Why?
|
| Hyperinsulinism | 1 | 2015 | 12 | 0.140 |
Why?
|
| Hip Fractures | 2 | 2012 | 30 | 0.130 |
Why?
|
| Phenotype | 5 | 2015 | 629 | 0.130 |
Why?
|
| Insulin-Secreting Cells | 1 | 2015 | 53 | 0.130 |
Why?
|
| Epistasis, Genetic | 1 | 2015 | 44 | 0.130 |
Why?
|
| Single-Blind Method | 1 | 2015 | 165 | 0.130 |
Why?
|
| Hyperglycemia | 1 | 2015 | 82 | 0.130 |
Why?
|
| Coffea | 1 | 2014 | 1 | 0.130 |
Why?
|
| Feasibility Studies | 1 | 2015 | 263 | 0.130 |
Why?
|
| Oxidoreductases Acting on CH-CH Group Donors | 1 | 2014 | 9 | 0.130 |
Why?
|
| Hearing Loss | 1 | 2014 | 19 | 0.120 |
Why?
|
| Antidepressive Agents | 1 | 2014 | 70 | 0.120 |
Why?
|
| Apolipoprotein E4 | 1 | 2014 | 58 | 0.120 |
Why?
|
| Health Surveys | 2 | 2011 | 191 | 0.120 |
Why?
|
| Phosphoric Monoester Hydrolases | 1 | 2013 | 11 | 0.120 |
Why?
|
| Genetic Variation | 2 | 2012 | 251 | 0.120 |
Why?
|
| Adiposity | 2 | 2012 | 191 | 0.120 |
Why?
|
| Health Education | 1 | 2014 | 121 | 0.120 |
Why?
|
| Fasting | 2 | 2012 | 93 | 0.120 |
Why?
|
| Muscle Weakness | 1 | 2014 | 39 | 0.120 |
Why?
|
| Predictive Value of Tests | 3 | 2014 | 787 | 0.120 |
Why?
|
| Nutrition Surveys | 5 | 2013 | 134 | 0.120 |
Why?
|
| Homozygote | 2 | 2010 | 57 | 0.120 |
Why?
|
| PPAR gamma | 2 | 2011 | 45 | 0.120 |
Why?
|
| Calcium, Dietary | 1 | 2013 | 23 | 0.110 |
Why?
|
| Trace Elements | 1 | 2013 | 7 | 0.110 |
Why?
|
| Carbohydrate Metabolism | 1 | 2012 | 13 | 0.110 |
Why?
|
| Magnesium | 1 | 2013 | 22 | 0.110 |
Why?
|
| Lipoprotein Lipase | 1 | 2012 | 14 | 0.110 |
Why?
|
| Receptors, Calcitriol | 1 | 2012 | 10 | 0.110 |
Why?
|
| Hyperparathyroidism | 1 | 2012 | 7 | 0.110 |
Why?
|
| Heart Failure | 1 | 2018 | 568 | 0.110 |
Why?
|
| Vitamin B 12 Deficiency | 1 | 2012 | 5 | 0.110 |
Why?
|
| Seasons | 4 | 2015 | 84 | 0.110 |
Why?
|
| Gene Frequency | 3 | 2018 | 225 | 0.110 |
Why?
|
| Insulin Resistance | 1 | 2015 | 449 | 0.110 |
Why?
|
| Exercise Therapy | 1 | 2014 | 229 | 0.110 |
Why?
|
| Homeostasis | 1 | 2012 | 127 | 0.110 |
Why?
|
| Urban Population | 1 | 2012 | 79 | 0.110 |
Why?
|
| Linkage Disequilibrium | 4 | 2013 | 192 | 0.110 |
Why?
|
| Peripheral Nervous System Diseases | 1 | 2012 | 45 | 0.100 |
Why?
|
| Socioeconomic Factors | 2 | 2014 | 391 | 0.100 |
Why?
|
| Knee | 1 | 2011 | 31 | 0.100 |
Why?
|
| Cation Transport Proteins | 1 | 2011 | 24 | 0.100 |
Why?
|
| Lipids | 1 | 2012 | 209 | 0.100 |
Why?
|
| Zinc | 1 | 2011 | 32 | 0.100 |
Why?
|
| Calcium | 1 | 2013 | 296 | 0.100 |
Why?
|
| Reference Values | 1 | 2011 | 224 | 0.100 |
Why?
|
| Pain Measurement | 1 | 2012 | 364 | 0.100 |
Why?
|
| Anthropometry | 2 | 2014 | 82 | 0.100 |
Why?
|
| Multicenter Studies as Topic | 1 | 2011 | 92 | 0.100 |
Why?
|
| Case-Control Studies | 3 | 2018 | 859 | 0.100 |
Why?
|
| Thiazolidinediones | 1 | 2011 | 47 | 0.100 |
Why?
|
| MicroRNAs | 1 | 2012 | 173 | 0.090 |
Why?
|
| Fractures, Bone | 1 | 2012 | 149 | 0.090 |
Why?
|
| Resistance Training | 1 | 2011 | 70 | 0.090 |
Why?
|
| Body Fat Distribution | 1 | 2010 | 34 | 0.090 |
Why?
|
| Hypertension | 2 | 2014 | 906 | 0.090 |
Why?
|
| Europe | 3 | 2017 | 77 | 0.090 |
Why?
|
| Inflammation Mediators | 1 | 2010 | 101 | 0.090 |
Why?
|
| Hypoglycemic Agents | 1 | 2011 | 176 | 0.090 |
Why?
|
| Energy Metabolism | 1 | 2010 | 139 | 0.080 |
Why?
|
| Physical Endurance | 1 | 2008 | 31 | 0.080 |
Why?
|
| Age Distribution | 1 | 2009 | 198 | 0.080 |
Why?
|
| Health Status Disparities | 1 | 2009 | 113 | 0.080 |
Why?
|
| Oxygen Consumption | 2 | 2019 | 138 | 0.080 |
Why?
|
| Logistic Models | 2 | 2011 | 727 | 0.080 |
Why?
|
| Hospitalization | 1 | 2010 | 417 | 0.080 |
Why?
|
| Arteriosclerosis | 2 | 2005 | 116 | 0.080 |
Why?
|
| Exercise Test | 2 | 2019 | 194 | 0.080 |
Why?
|
| Atherosclerosis | 2 | 2013 | 693 | 0.070 |
Why?
|
| Patient Selection | 1 | 2008 | 257 | 0.070 |
Why?
|
| Sex Distribution | 1 | 2007 | 186 | 0.070 |
Why?
|
| Forced Expiratory Volume | 2 | 2018 | 112 | 0.070 |
Why?
|
| Prognosis | 3 | 2018 | 1362 | 0.070 |
Why?
|
| Fibroblast Growth Factors | 2 | 2018 | 34 | 0.070 |
Why?
|
| Cardiovascular Diseases | 1 | 2013 | 1013 | 0.070 |
Why?
|
| Quality of Life | 1 | 2011 | 816 | 0.070 |
Why?
|
| Regression Analysis | 2 | 2018 | 274 | 0.070 |
Why?
|
| Multivariate Analysis | 2 | 2018 | 637 | 0.060 |
Why?
|
| Neuropsychological Tests | 2 | 2016 | 379 | 0.060 |
Why?
|
| Retrospective Studies | 2 | 2008 | 3111 | 0.060 |
Why?
|
| Adaptor Proteins, Signal Transducing | 2 | 2014 | 65 | 0.060 |
Why?
|
| Quantitative Trait Loci | 2 | 2013 | 140 | 0.060 |
Why?
|
| Dietary Fiber | 1 | 2002 | 19 | 0.060 |
Why?
|
| Risk | 2 | 2014 | 289 | 0.060 |
Why?
|
| Cause of Death | 2 | 2012 | 220 | 0.050 |
Why?
|
| Smoking | 2 | 2018 | 427 | 0.050 |
Why?
|
| Abdominal Fat | 2 | 2011 | 46 | 0.050 |
Why?
|
| Subcutaneous Fat | 2 | 2011 | 42 | 0.050 |
Why?
|
| Cluster Analysis | 2 | 2011 | 128 | 0.050 |
Why?
|
| Dose-Response Relationship, Drug | 2 | 2014 | 641 | 0.040 |
Why?
|
| Residence Characteristics | 2 | 2012 | 181 | 0.040 |
Why?
|
| Tomography | 1 | 2019 | 4 | 0.040 |
Why?
|
| Young Adult | 2 | 2018 | 2402 | 0.040 |
Why?
|
| Hip | 1 | 2019 | 13 | 0.040 |
Why?
|
| Fatigue | 1 | 2019 | 68 | 0.040 |
Why?
|
| Survival Analysis | 2 | 2011 | 440 | 0.040 |
Why?
|
| Molecular Epidemiology | 1 | 2018 | 20 | 0.040 |
Why?
|
| Vital Capacity | 1 | 2018 | 44 | 0.040 |
Why?
|
| Receptors, Retinoic Acid | 1 | 2018 | 9 | 0.040 |
Why?
|
| Femur | 1 | 2019 | 67 | 0.040 |
Why?
|
| Exercise Tolerance | 1 | 2019 | 110 | 0.040 |
Why?
|
| Lumbar Vertebrae | 1 | 2019 | 98 | 0.040 |
Why?
|
| Amidohydrolases | 1 | 2018 | 8 | 0.040 |
Why?
|
| Myosin-Light-Chain Phosphatase | 1 | 2017 | 1 | 0.040 |
Why?
|
| Hispanic Americans | 2 | 2018 | 904 | 0.040 |
Why?
|
| Health Services for the Aged | 1 | 2018 | 25 | 0.040 |
Why?
|
| Actins | 1 | 2017 | 52 | 0.040 |
Why?
|
| Genomics | 1 | 2018 | 82 | 0.040 |
Why?
|
| Autoimmune Diseases | 1 | 2018 | 50 | 0.040 |
Why?
|
| Posture | 1 | 2017 | 53 | 0.040 |
Why?
|
| Postural Balance | 1 | 2017 | 160 | 0.030 |
Why?
|
| Publication Bias | 1 | 2015 | 5 | 0.030 |
Why?
|
| Vitamin D-Binding Protein | 1 | 2015 | 10 | 0.030 |
Why?
|
| Genetic Association Studies | 1 | 2015 | 148 | 0.030 |
Why?
|
| Basic Helix-Loop-Helix Leucine Zipper Transcription Factors | 1 | 2014 | 1 | 0.030 |
Why?
|
| Cytochrome P-450 CYP1A2 | 1 | 2014 | 3 | 0.030 |
Why?
|
| Severity of Illness Index | 1 | 2018 | 863 | 0.030 |
Why?
|
| Brain-Derived Neurotrophic Factor | 1 | 2014 | 36 | 0.030 |
Why?
|
| Asian Continental Ancestry Group | 1 | 2014 | 110 | 0.030 |
Why?
|
| 25-Hydroxyvitamin D 2 | 1 | 2014 | 1 | 0.030 |
Why?
|
| Georgia | 1 | 2014 | 13 | 0.030 |
Why?
|
| Calcifediol | 1 | 2014 | 7 | 0.030 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2013 | 155 | 0.030 |
Why?
|
| National Institutes of Health (U.S.) | 1 | 2013 | 28 | 0.030 |
Why?
|
| Metagenomics | 1 | 2013 | 3 | 0.030 |
Why?
|
| TRPM Cation Channels | 1 | 2013 | 3 | 0.030 |
Why?
|
| North America | 1 | 2013 | 33 | 0.030 |
Why?
|
| Steroid Hydroxylases | 1 | 2012 | 2 | 0.030 |
Why?
|
| 25-Hydroxyvitamin D3 1-alpha-Hydroxylase | 1 | 2012 | 5 | 0.030 |
Why?
|
| Sensitivity and Specificity | 1 | 2014 | 532 | 0.030 |
Why?
|
| Medicare | 1 | 2014 | 186 | 0.030 |
Why?
|
| Meta-Analysis as Topic | 1 | 2012 | 39 | 0.030 |
Why?
|
| Epithelial Cells | 1 | 2013 | 138 | 0.030 |
Why?
|
| Genetic Markers | 1 | 2012 | 122 | 0.030 |
Why?
|
| Receptors, Cell Surface | 1 | 2012 | 72 | 0.030 |
Why?
|
| Chromosome Mapping | 1 | 2013 | 190 | 0.030 |
Why?
|
| Cholesterol, HDL | 1 | 2012 | 165 | 0.030 |
Why?
|
| Lipid Metabolism | 1 | 2012 | 100 | 0.030 |
Why?
|
| Triglycerides | 1 | 2012 | 214 | 0.030 |
Why?
|
| Child | 1 | 2018 | 2219 | 0.030 |
Why?
|
| Distance Perception | 1 | 2011 | 3 | 0.030 |
Why?
|
| Intention | 1 | 2011 | 27 | 0.030 |
Why?
|
| Judgment | 1 | 2011 | 11 | 0.030 |
Why?
|
| Evidence-Based Medicine | 1 | 2013 | 207 | 0.030 |
Why?
|
| Continental Population Groups | 1 | 2013 | 221 | 0.030 |
Why?
|
| Arm | 1 | 2011 | 31 | 0.020 |
Why?
|
| Analysis of Variance | 1 | 2012 | 454 | 0.020 |
Why?
|
| Choristoma | 1 | 2011 | 17 | 0.020 |
Why?
|
| Organ Size | 1 | 2011 | 196 | 0.020 |
Why?
|
| Psychomotor Performance | 1 | 2011 | 97 | 0.020 |
Why?
|
| Chromosomes, Human, Pair 4 | 1 | 2010 | 10 | 0.020 |
Why?
|
| Chromosomes, Human, Pair 11 | 1 | 2010 | 24 | 0.020 |
Why?
|
| Immunoassay | 1 | 2010 | 11 | 0.020 |
Why?
|
| Canada | 1 | 2010 | 48 | 0.020 |
Why?
|
| International Cooperation | 1 | 2010 | 25 | 0.020 |
Why?
|
| Heterozygote | 1 | 2010 | 52 | 0.020 |
Why?
|
| Adipokines | 1 | 2010 | 15 | 0.020 |
Why?
|
| Adolescent | 1 | 2018 | 3254 | 0.020 |
Why?
|
| Diet, Fat-Restricted | 1 | 2010 | 30 | 0.020 |
Why?
|
| Water | 1 | 2010 | 50 | 0.020 |
Why?
|
| Self Disclosure | 1 | 2010 | 23 | 0.020 |
Why?
|
| Gene Expression Regulation | 1 | 2012 | 481 | 0.020 |
Why?
|
| Staining and Labeling | 1 | 2010 | 56 | 0.020 |
Why?
|
| Baltimore | 1 | 2009 | 49 | 0.020 |
Why?
|
| Waist Circumference | 1 | 2009 | 89 | 0.020 |
Why?
|
| Polymorphism, Genetic | 1 | 2010 | 196 | 0.020 |
Why?
|
| Myocardial Infarction | 1 | 2012 | 412 | 0.020 |
Why?
|
| Combined Modality Therapy | 1 | 2008 | 525 | 0.020 |
Why?
|
| Neoplasms | 1 | 2012 | 610 | 0.020 |
Why?
|
| Postmenopause | 1 | 2008 | 397 | 0.020 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2011 | 871 | 0.020 |
Why?
|
| Alcohol Drinking | 1 | 2007 | 244 | 0.020 |
Why?
|
| North Carolina | 1 | 2002 | 1423 | 0.010 |
Why?
|